Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 16:31 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
GrantPerformance Shares · Derivative | 4,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008590 · form4.xml · derivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030 Underlying: Common Stock · 4,030 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:31 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
GrantCommon Stock | 10,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008590 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,022 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC |
Rollins CarissaSVP, Chief Information Officer
|
GrantPerformance Shares · Derivative | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · derivative · entry 3 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Common Stock · 3,023 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC |
Rollins CarissaSVP, Chief Information Officer
|
GrantPerformance Shares · Derivative | 2,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015 Underlying: Common Stock · 2,015 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:28 UTC |
Rollins CarissaSVP, Chief Information Officer
|
GrantCommon Stock | 5,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008589 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,612 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:26 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantPerformance Shares · Derivative | 4,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008588 · form4.xml · derivative · entry 3 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 Underlying: Common Stock · 4,156 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:26 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantPerformance Shares · Derivative | 2,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008588 · form4.xml · derivative · entry 2 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,771 Underlying: Common Stock · 2,771 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:26 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantCommon Stock | 6,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008588 · form4.xml · nonDerivative · entry 1 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,195 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:24 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantPerformance Shares · Derivative | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008587 · form4.xml · derivative · entry 3 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Common Stock · 3,023 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:24 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantPerformance Shares · Derivative | 2,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008587 · form4.xml · derivative · entry 2 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,015 Underlying: Common Stock · 2,015 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:24 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantCommon Stock | 5,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008587 · form4.xml · nonDerivative · entry 1 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,167 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:22 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 4,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008584 · form4.xml · derivative · entry 4 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 Underlying: Common Stock · 4,156 shares Expires 2025-12-28 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:22 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 2,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008584 · form4.xml · derivative · entry 3 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,771 Underlying: Common Stock · 2,771 shares Expires 2024-12-29 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:22 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantCommon Stock | 6,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008584 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,807 F2 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:22 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 3,917 | $199.06 | $779,737.21 |
DisclosureSEC source: 0001127602-23-008584 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:19 UTC |
GOSWAMI JOYDEEPSVP Chief Financial Officer
|
GrantPerformance Shares · Derivative | 6,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008581 · form4.xml · derivative · entry 3 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,045 Underlying: Common Stock · 6,045 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:19 UTC |
GOSWAMI JOYDEEPSVP Chief Financial Officer
|
GrantPerformance Shares · Derivative | 4,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008581 · form4.xml · derivative · entry 2 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030 Underlying: Common Stock · 4,030 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:19 UTC |
GOSWAMI JOYDEEPSVP Chief Financial Officer
|
GrantCommon Stock | 10,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008581 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,726 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:16 UTC |
Frank John EdwardChief Public Affairs Officer
|
GrantPerformance Shares · Derivative | 4,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008579 · form4.xml · derivative · entry 3 Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Underlying: Common Stock · 4,534 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:16 UTC |
Frank John EdwardChief Public Affairs Officer
|
GrantPerformance Shares · Derivative | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008579 · form4.xml · derivative · entry 2 Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Common Stock · 3,023 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:16 UTC |
Frank John EdwardChief Public Affairs Officer
|
GrantCommon Stock | 7,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008579 · form4.xml · nonDerivative · entry 1 Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,270 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:14 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantPerformance Shares · Derivative | 4,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008575 · form4.xml · derivative · entry 3 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Underlying: Common Stock · 4,534 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:14 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantPerformance Shares · Derivative | 3,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008575 · form4.xml · derivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,023 Underlying: Common Stock · 3,023 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:14 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantCommon Stock | 7,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008575 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,786 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:12 UTC |
Ericksen Scott DVP, Chief Accounting Officer
|
GrantPerformance Shares · Derivative | 983 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008573 · form4.xml · derivative · entry 3 Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983 Underlying: Common Stock · 983 shares Expires 2025-12-28 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:12 UTC |
Ericksen Scott DVP, Chief Accounting Officer
|
GrantPerformance Shares · Derivative | 655 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008573 · form4.xml · derivative · entry 2 Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655 Underlying: Common Stock · 655 shares Expires 2024-12-29 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:12 UTC |
Ericksen Scott DVP, Chief Accounting Officer
|
GrantCommon Stock | 1,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008573 · form4.xml · nonDerivative · entry 1 Ericksen Scott D · CIK 0001950482 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 25 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:09 UTC |
deSouza Francis ADirector · President and CEO
|
GrantPerformance Shares · Derivative | 18,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008569 · form4.xml · derivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,888 Underlying: Common Stock · 18,888 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:09 UTC |
deSouza Francis ADirector · President and CEO
|
GrantPerformance Shares · Derivative | 12,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008569 · form4.xml · derivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,592 Underlying: Common Stock · 12,592 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:09 UTC |
deSouza Francis ADirector · President and CEO
|
GrantCommon Stock | 31,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008569 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,992 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:04 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantPerformance Shares · Derivative | 4,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008566 · form4.xml · derivative · entry 3 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 Underlying: Common Stock · 4,156 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:04 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantPerformance Shares · Derivative | 2,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008566 · form4.xml · derivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,771 Underlying: Common Stock · 2,771 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:04 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 6,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008566 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 16,967 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:02 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantPerformance Shares · Derivative | 6,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008564 · form4.xml · derivative · entry 3 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,045 Underlying: Common Stock · 6,045 shares Expires 2025-12-28 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:02 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantPerformance Shares · Derivative | 4,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008564 · form4.xml · derivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030 Underlying: Common Stock · 4,030 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:02 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantCommon Stock | 10,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008564 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,996 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 23:08 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 2,320 | $202.16 | $469,011.20 |
DisclosureSEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 4 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,922 F3 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 2,320 shares sold ranging from $201.89 to $202.65 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 23:08 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
SaleCommon Stock | 3,078 | $201.42 | $619,970.76 |
DisclosureSEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 3 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,242 F3 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 3,078 shares sold ranging from $200.88 to $201.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:08 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Exercise / conversionPerformance Shares · Derivative | 9,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006855 · form4.xml · derivative · entry 5 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,292 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:08 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Tax withholdingCommon Stock | 3,894 | $202.84 | $789,858.96 |
DisclosureSEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,320 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 23:08 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
Exercise / conversionCommon Stock | 9,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006855 · form4.xml · nonDerivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on July 6, 2020. F2 · balance_after: Balance includes 65 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:59 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionPerformance Shares · Derivative | 23,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006854 · form4.xml · derivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,473 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:59 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 10,907 | $202.84 | $2,212,375.88 |
DisclosureSEC source: 0001127602-23-006854 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,512 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:59 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 23,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006854 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. F2 · balance_after: Balance includes 90 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:55 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Exercise / conversionPerformance Shares · Derivative | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006853 · form4.xml · derivative · entry 3 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,869 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:55 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,197 | $202.84 | $445,639.48 |
DisclosureSEC source: 0001127602-23-006853 · form4.xml · nonDerivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,948 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:55 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006853 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:51 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
Exercise / conversionPerformance Shares · Derivative | 2,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006849 · form4.xml · derivative · entry 3 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,789 shares Expires 2023-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:51 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 704 | $202.84 | $142,799.36 |
DisclosureSEC source: 0001127602-23-006849 · form4.xml · nonDerivative · entry 2 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,269 Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:51 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 2,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006849 · form4.xml · nonDerivative · entry 1 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.